Document Type : Original Research

Authors

1 Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Ionizing and Non-ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran

3 School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4 Tehran Science and Research Branch, Islamic Azad University, Tehran, Iran

5 Biomedical Engineering Research Group, Research Center of Technology and Engineering, Standard Research Institute, Karaj, Iran

10.31661/jbpe.v0i0.2211-1557

Abstract

Background: Coronary heart disease the most prevalent form of cardiovascular disease, results from the blockage of blood flow through arteries. The Myocardial Perfusion Scan (MPS) is considered a non-invasive method to assess the heart condition and provides valuable information, such as End Diastolic Volume (EDV), End Systolic Volume (ESV), Ejection Fraction (EF), Lung to Heart Ratio (LHR), and Transient Ischemic Dilatation (TID).
Objective: This study aimed to investigate changes in gated heart scan parameters to diagnose patients, who are candidates for heart surgery.
Material and Methods: In this descriptive cross-sectional study, 40 patients who are candidates for heart surgery were enrolled to evaluate the relation between the parameters of the gated heart scan and the amount of ischemic area of the heart. After scanning the patients, TID, ESV, LHR, and EF and also the movements of the heart walls are examined and analyzed in these patients.
Results: According to the results of the one-sample t-test showing a significant difference between the parameters, the results were within the normal range (P-value<0.0001). Additionally, all patients showed changes in cardiac output and wall movement issues. 
Conclusion: The evaluation of Myocardial Perfusion Scan (MPS) and gated heart scan parameters can provide an effective method for diagnosing patients who may require heart surgery.

Highlights

Mohammad Mehdi Movahedi (Google Scholar)

Tahereh Mahmoudi (Google Scholar)

Keywords

  1. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. 2004;110(17):2678-86. doi: 10.1161/01.CIR.0000145615.33955.83. PubMed PMID: 15492305.
  2. Zaman MJ, Philipson P, Chen R, Farag A, Shipley M, Marmot MG, et al. South Asians and coronary disease: is there discordance between effects on incidence and prognosis? 2013;99(10):729-36. doi: 10.1136/heartjnl-2012-302925. PubMed PMID: 23406688. PubMed PMCID: PMC3960593.
  3. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342(16):1163-70. doi: 10.1056/NEJM200004203421603. PubMed PMID: 10770981.
  4. Kontos MC, Jesse RL, Schmidt KL, Ornato JP, Tatum JL. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol. 1997;30(4):976-82. doi: 10.1016/s0735-1097(97)00264-7. PubMed PMID: 9316527.
  5. Taqueti VR, Dorbala S, Wolinsky D, Abbott B, Heller GV, Bateman TM, et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol. 2017;24(4):1402-26. doi: 10.1007/s12350-017-0926-8. PubMed PMID: 28585034. PubMed PMCID: PMC5942593.
  6. Gani F, Jain D, Lahiri A. The role of cardiovascular imaging techniques in the assessment of patients with acute chest pain. Nucl Med Commun. 2007;28(6):441-9. doi: 10.1097/MNM.0b013e3281744491. PubMed PMID: 17460534.
  7. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol. 1993;71(2):166-72. doi: 10.1016/0002-9149(93)90733-s. PubMed PMID: 8421978.
  8. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med. 2007;48(7):1135-46. doi: 10.2967/jnumed.106.038851. PubMed PMID: 17574986.
  9. Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, et al. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging. J Nucl Cardiol. 2004;11(2):142-51. doi: 10.1016/j.nuclcard.2003.12.011. PubMed PMID: 15052245.
  10. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36(11):2138-47. PubMed PMID: 7472611.
  11. Travin MI, Heller GV, Johnson LL, Katten D, Ahlberg AW, Isasi CR, et al. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol. 2004;11(3):253-62. doi: 10.1016/j.nuclcard.2004.02.005. PubMed PMID: 15173772.
  12. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314(14):884-8. doi: 10.1056/NEJM198604033141405. PubMed PMID: 3485252.
  13. Grégoire J, Théroux P. Detection and assessment of unstable angina using myocardial perfusion imaging: comparison between technetium-99m sestamibi SPECT and 12-lead electrocardiogram. Am J Cardiol. 1990;66(13):42E-6. doi: 10.1016/0002-9149(90)90611-4. PubMed PMID: 2145745.
  14. Cai Q, Mukku VK, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev. 2013;9(4):331-9. doi: 10.2174/1573403x10666140214122234. PubMed PMID: 24527682. PubMed PMCID: PMC3941098.
  15. Hannoush H, Shaar K, Alam S, Nasrallah A, Sawaya J, Dakik HA. Analysis of referral patterns, predictive accuracy, and impact on patient management of myocardial perfusion imaging in a new nuclear cardiology laboratory. J Nucl Cardiol. 2003;10(2):148-53. doi: 10.1067/mnc.2003.397. PubMed PMID: 12673179.
  16. Chatterjee S. Commentary: Enhanced recovery after cardiac surgery: A game changer, passing fad, or somewhere in between? J Thorac Cardiovasc Surg. 2019;157(5):1889-90. doi: 10.1016/j.jtcvs.2018.11.046. PubMed PMID: 30635180.
  17. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e144-64. doi: 10.1016/j.jacc.2012.07.013. PubMed PMID: 23182125.
  18. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999-3054. doi: 10.1093/eurheartj/ehr236. PubMed PMID: 21873419.
  19. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31(2):261-91. doi: 10.1007/s00259-003-1344-5. PubMed PMID: 15129710. PubMed PMCID: PMC2562441.
  20. Alama M, Labos C, Emery H, Iwanochko RM, Freeman M, Husain M, Lee DS. Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: A systematic review and meta-analysis. J Nucl Cardiol. 2018;25(3):724-37. doi: 10.1007/s12350-017-1040-7. PubMed PMID: 28948540. PubMed PMCID: PMC5966496.
  21. Rahimtoola SH, Dilsizian V, Kramer CM, Marwick TH, Vanoverschelde JL. Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging. 2008;1(4):536-55. doi: 10.1016/j.jcmg.2008.05.009. PubMed PMID: 19356479. PubMed PMCID: PMC2664223.
  22. Kosaraju A, Goyal A, Grigorova Y, Makaryus AN. Left Ventricular Ejection Fraction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
  23. Caobelli F, Popescu CE, Laudicella R, Comis A, Pignata SA, Sara R, Rossetti C. Predictive and prognostic value of left ventricular mechanical dyssynchrony assessed by myocardial perfusion single photon emission computed tomography in asymptomatic patients under hemodialysis. Nucl Med Commun. 2018;39(5):423-9. doi: 10.1097/MNM.0000000000000816. PubMed PMID: 29629998.
  24. Hage FG, Venkataraman R, Aljaroudi W, Bravo PE, McLarry J, Faulkner M, et al. The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol. 2010;17(3):378-89. doi: 10.1007/s12350-010-9199-1. PubMed PMID: 20186583.
  25. Iskandrian AE, Garcia EV. Nuclear cardiac imaging: principles and applications. New York: Oxford University Press; 2008.
  26. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151-8. doi: 10.1016/s0735-1097(02)01726-6. PubMed PMID: 11923039.
  27. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 1995;75(12):759-62. doi: 10.1016/s0002-9149(99)80406-8. PubMed PMID: 7717274.
  28. D’Egidio G, Nichol G, Williams KA, Guo A, Garrard L, DeKemp R, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging. 2009;2(9):1060-8. doi: 10.1016/j.jcmg.2009.02.017. PubMed PMID: 19761983.
  29. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50(20):2002-12. doi: 10.1016/j.jacc.2007.09.006. PubMed PMID: 17996568.